Department of Biotechnology provides under Mission COVID Suraksha for Gennova Biopharmaceuticals Ltd.'s novel mRNA-based COVID 19 Vaccine candidate –HGCO19. – India Education| Global Education |Education News
Share Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC, moves into clinical trials The Department of Biotechnology (DBT), Ministry of Science & Technologyhas announced that it has approved additional funding towards clinical studies of India’s’first of its kind’ mRNA-based COVID-19 vaccine – HGCO19, developed by Pune-based biotechnology company Gennova Biopharmaceuticals Ltd. This funding has been awarded under the’Mission COVID Suraksha- Th...